80 related articles for article (PubMed ID: 11532979)
21. Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland.
Deans AJ; Simpson KJ; Trivett MK; Brown MA; McArthur GA
Oncogene; 2004 Aug; 23(36):6136-45. PubMed ID: 15208652
[TBL] [Abstract][Full Text] [Related]
22. [Role of the p27 cell-cycle inhibitor during vascular remodeling].
Andrés V; Díez-Juan A
Nefrologia; 2002; 22 Suppl 5():17-20. PubMed ID: 12107911
[No Abstract] [Full Text] [Related]
23. Roles for p21waf1/cip1 and p27kip1 during the adaptation response to massive intestinal resection.
Stehr W; Bernal NP; Erwin CR; Bernabe KQ; Guo J; Warner BW
Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G933-41. PubMed ID: 16322092
[TBL] [Abstract][Full Text] [Related]
24. Distinct roles for p53, p27Kip1, and p21Cip1 during tumor development.
Philipp-Staheli J; Kim KH; Liggitt D; Gurley KE; Longton G; Kemp CJ
Oncogene; 2004 Jan; 23(4):905-13. PubMed ID: 14647411
[TBL] [Abstract][Full Text] [Related]
25. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
26. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
27. Tyrphostin AG490 reduces NAPDH oxidase activity and expression in the aorta of hypercholesterolemic apolipoprotein E-deficient mice.
Fenyo IM; Florea IC; Raicu M; Manea A
Vascul Pharmacol; 2011; 54(3-6):100-6. PubMed ID: 21457788
[TBL] [Abstract][Full Text] [Related]
28. STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1).
de Koning JP; Soede-Bobok AA; Ward AC; Schelen AM; Antonissen C; van Leeuwen D; Löwenberg B; Touw IP
Oncogene; 2000 Jul; 19(29):3290-8. PubMed ID: 10918585
[TBL] [Abstract][Full Text] [Related]
29. pRb2/p130, vascular endothelial growth factor, p27(KIP1), and proliferating cell nuclear antigen expression in hepatocellular carcinoma: their clinical significance.
Claudio PP; Russo G; Kumar CA; Minimo C; Farina A; Tutton S; Nuzzo G; Giuliante F; Angeloni G; Maria V; Vecchio FM; Campli CD; Giordano A
Clin Cancer Res; 2004 May; 10(10):3509-17. PubMed ID: 15161709
[TBL] [Abstract][Full Text] [Related]
30. p27(Kip1)-stathmin interaction influences sarcoma cell migration and invasion.
Baldassarre G; Belletti B; Nicoloso MS; Schiappacassi M; Vecchione A; Spessotto P; Morrione A; Canzonieri V; Colombatti A
Cancer Cell; 2005 Jan; 7(1):51-63. PubMed ID: 15652749
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus X protein increases expression of p21(Cip-1/WAF1/MDA6) and p27(Kip-1) in primary mouse hepatocytes, leading to reduced cell cycle progression.
Qiao L; Leach K; McKinstry R; Gilfor D; Yacoub A; Park JS; Grant S; Hylemon PB; Fisher PB; Dent P
Hepatology; 2001 Nov; 34(5):906-17. PubMed ID: 11679961
[TBL] [Abstract][Full Text] [Related]
32. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1).
Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W
Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483
[TBL] [Abstract][Full Text] [Related]
33. Deficiency of cyclin-dependent kinase inhibitors p21Cip1 and p27Kip1 accelerates atherogenesis in apolipoprotein E-deficient mice.
Akyürek LM; Boehm M; Olive M; Zhou AX; San H; Nabel EG
Biochem Biophys Res Commun; 2010 May; 396(2):359-63. PubMed ID: 20417618
[TBL] [Abstract][Full Text] [Related]
34. Minocycline reduces plaque size in diet induced atherosclerosis via p27(Kip1).
Shahzad K; Thati M; Wang H; Kashif M; Wolter J; Ranjan S; He T; Zhou Q; Blessing E; Bierhaus A; Nawroth PP; Isermann B
Atherosclerosis; 2011 Nov; 219(1):74-83. PubMed ID: 21719015
[TBL] [Abstract][Full Text] [Related]
35. Mitochondrial integrity and function in atherogenesis.
Ballinger SW; Patterson C; Knight-Lozano CA; Burow DL; Conklin CA; Hu Z; Reuf J; Horaist C; Lebovitz R; Hunter GC; McIntyre K; Runge MS
Circulation; 2002 Jul; 106(5):544-9. PubMed ID: 12147534
[TBL] [Abstract][Full Text] [Related]
36. Interaction of diet and genes in atherogenesis. Report of an NHLBI working group.
Tall A; Welch C; Applebaum-Bowden D; Wassef M
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3326-31. PubMed ID: 9409329
[TBL] [Abstract][Full Text] [Related]
37. Gravin gravitates atherogenesis to atheroprogression in the obesogenic setting.
Kain V; Halade GV
Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H790-H792. PubMed ID: 31518153
[No Abstract] [Full Text] [Related]
38. BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E-Deficient Mice.
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28743785
[No Abstract] [Full Text] [Related]
39. Therapeutic Potential of Targeting p27
Trinh J; Shin J; Rai V; Agrawal DK
Arch Intern Med Res; 2024; 7(2):73-79. PubMed ID: 38737892
[TBL] [Abstract][Full Text] [Related]
40. Comparative Proteome Analysis of Epicardial and Subcutaneous Adipose Tissues from Patients with or without Coronary Artery Disease.
Zhao YX; Zhu HJ; Pan H; Liu XM; Wang LJ; Yang HB; Li NS; Gong FY; Sun W; Zeng Y
Int J Endocrinol; 2019; 2019():6976712. PubMed ID: 31534454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
